{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:13:55Z","timestamp":1784052835319,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00520-026-10869-7","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:08:52Z","timestamp":1781186932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations of symptom burden with patient-reported outcomes and clinical outcomes among early phase cancer clinical trial participants"],"prefix":"10.1007","volume":"34","author":[{"given":"Anh B.","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sienna M.","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Boulanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Bame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Yalala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Ollila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Malowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casandra","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Juric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Lundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan David","family":"Nipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"10869_CR1","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1007\/s00520-018-4632-0","volume":"27","author":"TR Mendoza","year":"2019","unstructured":"Mendoza TR, Kehl KL, Bamidele O, Williams LA, Shi Q, Cleeland CS, Simon G (2019) Assessment of baseline symptom burden in treatment-na\u00efve patients with lung cancer: an observational study. Support Care Cancer 27:3439\u20133447. https:\/\/doi.org\/10.1007\/s00520-018-4632-0","journal-title":"Support Care Cancer"},{"key":"10869_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1188\/24.Onf.361-380","volume":"51","author":"KP Singh","year":"2024","unstructured":"Singh KP, Cooper BA, Paul SM, Ruddy K, Singh AB, Chen J, Pituch KA, Grys TE, Singh P, Batalini F et al (2024) Gastrointestinal and Neuropsychological Symptoms Are Associated With Distinct Vomiting Profiles in Patients Receiving Chemotherapy. Oncol Nurs Forum 51:361\u2013380. https:\/\/doi.org\/10.1188\/24.Onf.361-380","journal-title":"Oncol Nurs Forum"},{"key":"10869_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1089\/jpm.2018.0202","volume":"22","author":"T Knox-Rice","year":"2019","unstructured":"Knox-Rice T, Xuan L, Wadsworth H, Halm EA, Rhodes RL (2019) Examining the Association between Healthcare Utilization and Clinical Characteristics among Cancer Patients in a Safety Net Health System. J Palliat Med 22:80\u201383. https:\/\/doi.org\/10.1089\/jpm.2018.0202","journal-title":"J Palliat Med"},{"key":"10869_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae083","author":"MJ Bouvette","year":"2024","unstructured":"Bouvette MJ, Lam AB, Bouvette C, Ayanambakkam A, Nipp RD (2024) Oncology drug pricing: potential medicare savings on cancer-directed and supportive care medications through the Mark Cuban cost plus drug model. Oncologist. https:\/\/doi.org\/10.1093\/oncolo\/oyae083","journal-title":"Oncologist"},{"key":"10869_CR5","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1002\/cncr.32833","volume":"126","author":"RA Newcomb","year":"2020","unstructured":"Newcomb RA, Nipp RD, Waldman LP, Greer JA, Lage DE, Hochberg EP, Jackson VA, Fuh CX, Ryan DP, Temel Jea, Fuh C\u2010X et al (2020) Symptom burden in patients with cancer who are experiencing unplanned hospitalization. Cancer 126:2924\u20132933. https:\/\/doi.org\/10.1002\/cncr.32833","journal-title":"Cancer"},{"key":"10869_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgm005","author":"CS Cleeland","year":"2007","unstructured":"Cleeland CS (2007) Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr. https:\/\/doi.org\/10.1093\/jncimonographs\/lgm005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10869_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cllc.2017.02.008","volume":"18","author":"EJ Morrison","year":"2017","unstructured":"Morrison EJ, Novotny PJ, Sloan JA, Yang P, Patten CA, Ruddy KJ, Clark MM (2017) Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer. Clin Lung Cancer 18:497\u2013503. https:\/\/doi.org\/10.1016\/j.cllc.2017.02.008","journal-title":"Clin Lung Cancer"},{"key":"10869_CR8","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s00520-020-05623-6","volume":"29","author":"A Batra","year":"2021","unstructured":"Batra A, Yang L, Boyne DJ, Harper A, Cheung WY, Cuthbert CA (2021) Associations between baseline symptom burden as assessed by patient-reported outcomes and overall survival of patients with metastatic cancer. Support Care Cancer 29:1423\u20131431. https:\/\/doi.org\/10.1007\/s00520-020-05623-6","journal-title":"Support Care Cancer"},{"key":"10869_CR9","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jpainsymman.2022.02.013","volume":"63","author":"JJ Koldenhof","year":"2022","unstructured":"Koldenhof JJ, van der Baan FH, Verberne EG, Kamphuis AM, Verheijden RJ, Tonk EH, van Lindert AS, van der Stap J, Teunissen SC, Witteveen Pea et al (2022) Patient-reported outcomes during checkpoint inhibition: insight into symptom burden in daily clinical practice. J Pain Symptom Manage 63:997\u20131005. https:\/\/doi.org\/10.1016\/j.jpainsymman.2022.02.013","journal-title":"J Pain Symptom Manage"},{"key":"10869_CR10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/jnci\/djad174","volume":"115","author":"MC Boulanger","year":"2023","unstructured":"Boulanger MC, Petrillo LA, Temel JS (2023) Listen to the patient: integrating patient-reported outcomes into clinical care. J Natl Cancer Inst 115:1451\u20131453. https:\/\/doi.org\/10.1093\/jnci\/djad174","journal-title":"J Natl Cancer Inst"},{"key":"10869_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2023.104588","volume":"147","author":"Y Li","year":"2023","unstructured":"Li Y, Li J, Hu X (2023) The effectiveness of symptom management interventions based on electronic patient-reported outcomes (ePROs) for symptom burden, quality of life, and overall survival among patients with cancer: a meta-analysis of randomized controlled trials. Int J Nurs Stud 147:104588, 104588. https:\/\/doi.org\/10.1016\/j.ijnurstu.2023.104588","journal-title":"Int J Nurs Stud"},{"key":"10869_CR12","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1001\/jama.2022.9265","volume":"327","author":"E Basch","year":"2022","unstructured":"Basch E, Schrag D, Henson S, Jansen J, Ginos B, Stover AM, Carr P, Spears PA, Jonsson M, Deal Aea et al (2022) Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. JAMA 327:2413\u20132422. https:\/\/doi.org\/10.1001\/jama.2022.9265","journal-title":"JAMA"},{"key":"10869_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/jco.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson Tea et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34:557\u2013565. https:\/\/doi.org\/10.1200\/jco.2015.63.0830","journal-title":"J Clin Oncol"},{"key":"10869_CR14","unstructured":"Institute, N.C. What Are Clinical Trials? . Available online: https:\/\/www.cancer.gov\/research\/participate\/clinical-trials\/what-are-clinical-trials (accessed on May 3)."},{"key":"10869_CR15","unstructured":"Society, A.C. Types and Phases of Clinical Trials. Available online: https:\/\/www.cancer.org\/cancer\/managing-cancer\/making-treatment-decisions\/clinical-trials\/what-you-need-to-know\/phases-of-clinical-trials.html (accessed on May 3)."},{"key":"10869_CR16","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1158\/1078-0432.Ccr-09-1961","volume":"16","author":"SP Ivy","year":"2010","unstructured":"Ivy SP, Siu LL, Garrett-Mayer E, Rubinstein L (2010) Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the National Cancer Institute investigational drug steering committee. Clin Cancer Res 16:1726\u20131736. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-09-1961","journal-title":"Clin Cancer Res"},{"key":"10869_CR17","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1001\/jama.292.17.2130","volume":"292","author":"TG Roberts Jr","year":"2004","unstructured":"Roberts TG Jr, Goulart BH, Squitieri L, Stallings SC, Halpern EF, Chabner BA, Gazelle GS, Finkelstein SN, Clark JW (2004) Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA 292:2130\u20132140. https:\/\/doi.org\/10.1001\/jama.292.17.2130","journal-title":"JAMA"},{"key":"10869_CR18","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1002\/cncr.30182","volume":"122","author":"GC George","year":"2016","unstructured":"George GC, Iwuanyanwu EC, Anderson KO, Yusuf A, Zinner RG, Piha-Paul SA, Tsimberidou AM, Naing A, Fu S, Janku Fea et al (2016) Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials. Cancer 122:3401\u20133409. https:\/\/doi.org\/10.1002\/cncr.30182","journal-title":"Cancer"},{"key":"10869_CR19","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/jocn.14803","volume":"28","author":"K Lee","year":"2019","unstructured":"Lee K, Oh EG, Kim S, Kim SW (2019) Symptom experiences and health-related quality of life among non-small cell lung cancer patients participating in clinical trials. J Clin Nurs 28:2111\u20132123. https:\/\/doi.org\/10.1111\/jocn.14803","journal-title":"J Clin Nurs"},{"key":"10869_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00520-017-3879-1","volume":"26","author":"M Treasure","year":"2018","unstructured":"Treasure M, Daly B, Fu P, Kerpedjieva S, Dowlati A, Meropol NJ (2018) Relationship between phase I study duration and symptom burden. Support Care Cancer 26:731\u2013737. https:\/\/doi.org\/10.1007\/s00520-017-3879-1","journal-title":"Support Care Cancer"},{"key":"10869_CR21","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s10637-019-00879-0","volume":"38","author":"GC George","year":"2020","unstructured":"George GC, Mendoza TR, Iwuanyanwu EC, Manandhar M, Afshar SF, Piha-Paul SA, Tsimberidou A, Naing A, Cleeland CS, Hong DS (2020) Factors affecting symptom presentation in an early-phase clinical trials clinic patient population. Invest New Drugs 38:1166\u20131174. https:\/\/doi.org\/10.1007\/s10637-019-00879-0","journal-title":"Invest New Drugs"},{"key":"10869_CR22","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1002\/cam4.3971","volume":"10","author":"M Treasure","year":"2021","unstructured":"Treasure M, Daly B, Cao S, Fu P, Hong A, Weinstein E, Surdam J, Meropol NJ, Dowlati A (2021) A randomized controlled trial of structured palliative care versus standard supportive care for patients enrolled in phase 1 clinical trials. Cancer Med 10:4312\u20134321. https:\/\/doi.org\/10.1002\/cam4.3971","journal-title":"Cancer Med"},{"key":"10869_CR23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/sj.bjc.6602423","volume":"92","author":"ZA Nurgat","year":"2005","unstructured":"Nurgat ZA, Craig W, Campbell NC, Bissett JD, Cassidy J, Nicolson MC (2005) Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer 92:1001\u20131005. https:\/\/doi.org\/10.1038\/sj.bjc.6602423","journal-title":"Br J Cancer"},{"key":"10869_CR24","doi-asserted-by":"publisher","first-page":"e829","DOI":"10.1200\/op.22.00742","volume":"19","author":"DM Lundquist","year":"2023","unstructured":"Lundquist DM, Jimenez R, Durbin S, Horick N, Healy M, Johnson A, Bame V, Capasso V, McIntyre C, Cashavelly Bea et al (2023) Identifying early-phase clinical trial participants at risk for experiencing worse clinical outcomes. JCO Oncol Pract 19:e829\u2013e837. https:\/\/doi.org\/10.1200\/op.22.00742","journal-title":"JCO Oncol Pract"},{"key":"10869_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/082585979100700202","volume":"7","author":"E Bruera","year":"1991","unstructured":"Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6\u20139","journal-title":"J Palliat Care"},{"key":"10869_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jpainsymman.2016.10.370","volume":"53","author":"D Hui","year":"2017","unstructured":"Hui D, Bruera E (2017) The Edmonton symptom assessment system 25 years later: past, present, and future developments. J Pain Symptom Manage 53:630\u2013643. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.10.370","journal-title":"J Pain Symptom Manage"},{"key":"10869_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jpainsymman.2009.06.010","volume":"39","author":"D Selby","year":"2010","unstructured":"Selby D, Cascella A, Gardiner K, Do R, Moravan V, Myers J, Chow E (2010) A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manage 39:241\u2013249. https:\/\/doi.org\/10.1016\/j.jpainsymman.2009.06.010","journal-title":"J Pain Symptom Manage"},{"key":"10869_CR28","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1200\/jco.22.02775","volume":"41","author":"DF Cella","year":"2023","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (2023) The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 41:5335\u20135344. https:\/\/doi.org\/10.1200\/jco.22.02775","journal-title":"J Clin Oncol"},{"key":"10869_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2009.06.019","volume":"122","author":"B L\u00f6we","year":"2010","unstructured":"L\u00f6we B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Br\u00e4hler E (2010) A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 122:86\u201395. https:\/\/doi.org\/10.1016\/j.jad.2009.06.019","journal-title":"J Affect Disord"},{"key":"10869_CR30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","volume":"123","author":"JA de Souza","year":"2017","unstructured":"de Souza JA, Yap BJ, Wroblewski K, Blinder V, Ara\u00fajo FS, Hlubocky FJ, Nicholas LH, O\u2019Connor JM, Brockstein B, Ratain MJ et al (2017) Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST). Cancer 123:476\u2013484. https:\/\/doi.org\/10.1002\/cncr.30369","journal-title":"Cancer"},{"key":"10869_CR31","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.ejca.2014.04.030","volume":"50","author":"X Paoletti","year":"2014","unstructured":"Paoletti X, Le Tourneau C, Verweij J, Siu LL, Seymour L, Postel-Vinay S, Collette L, Rizzo E, Ivy P, Olmos Dea et al (2014) Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: results of a DLT-TARGETT international survey. Eur J Cancer 50:2050\u20132056. https:\/\/doi.org\/10.1016\/j.ejca.2014.04.030","journal-title":"Eur J Cancer"},{"key":"10869_CR32","first-page":"1121","volume":"11","author":"A Delgado","year":"2021","unstructured":"Delgado A, Guddati AK (2021) Clinical endpoints in oncology - a primer. Am J Cancer Res 11:1121\u20131131","journal-title":"Am J Cancer Res"},{"key":"10869_CR33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/PPO.0b013e3181b9c5ec","volume":"15","author":"D Lebwohl","year":"2009","unstructured":"Lebwohl D, Kay A, Berg W, Baladi JF, Zheng J (2009) Progression-free survival: gaining on overall survival as a gold standard and accelerating drug development. Cancer J 15:386\u2013394. https:\/\/doi.org\/10.1097\/PPO.0b013e3181b9c5ec","journal-title":"Cancer J"},{"key":"10869_CR34","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00520-013-2049-3","volume":"22","author":"TL Deshields","year":"2014","unstructured":"Deshields TL, Potter P, Olsen S, Liu J (2014) The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer 22:1089\u20131096. https:\/\/doi.org\/10.1007\/s00520-013-2049-3","journal-title":"Support Care Cancer"},{"key":"10869_CR35","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1002\/cncr.25681","volume":"116","author":"L Barbera","year":"2010","unstructured":"Barbera L, Seow H, Howell D, Sutradhar R, Earle C, Liu Y, Stitt A, Husain A, Sussman J, Dudgeon D (2010) Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer 116:5767\u20135776. https:\/\/doi.org\/10.1002\/cncr.25681","journal-title":"Cancer"},{"key":"10869_CR36","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1200\/jco.2017.76.0876","volume":"36","author":"LD Bubis","year":"2018","unstructured":"Bubis LD, Davis L, Mahar A, Barbera L, Li Q, Moody L, Karanicolas P, Sutradhar R, Coburn NG (2018) Symptom burden in the first year after cancer diagnosis: an analysis of patient-reported outcomes. J Clin Oncol 36:1103\u20131111. https:\/\/doi.org\/10.1200\/jco.2017.76.0876","journal-title":"J Clin Oncol"},{"key":"10869_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/jpm.2011.0219","volume":"15","author":"S Yennurajalingam","year":"2012","unstructured":"Yennurajalingam S, Atkinson B, Masterson J, Hui D, Urbauer D, Tu SM, Bruera E (2012) The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients. J Palliat Med 15:20\u201324. https:\/\/doi.org\/10.1089\/jpm.2011.0219","journal-title":"J Palliat Med"},{"key":"10869_CR38","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.4274","volume":"30","author":"P Royston","year":"2011","unstructured":"Royston P, Parmar MK (2011) The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Stat Med 30:2409\u20132421. https:\/\/doi.org\/10.1002\/sim.4274","journal-title":"Stat Med"},{"key":"10869_CR39","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1200\/op.23.00811","volume":"20","author":"SM Durbin","year":"2024","unstructured":"Durbin SM, Lundquist DM, Pelletier A, Jimenez R, Petrillo L, Kim J, Lynch K, Healy M, Johnson A, Ollila N et al (2024) Time toxicity experienced by early-phase cancer clinical trial participants. JCO Oncol Pract 20:1252\u20131262. https:\/\/doi.org\/10.1200\/op.23.00811","journal-title":"JCO Oncol Pract"},{"key":"10869_CR40","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00520-007-0216-0","volume":"15","author":"MZ Cohen","year":"2007","unstructured":"Cohen MZ, Slomka J, Pentz RD, Flamm AL, Gold D, Herbst RS, Abbruzzese JL (2007) Phase I participants\u2019 views of quality of life and trial participation burdens. Support Care Cancer 15:885\u2013890. https:\/\/doi.org\/10.1007\/s00520-007-0216-0","journal-title":"Support Care Cancer"},{"key":"10869_CR41","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1200\/jco.2010.30.7173","volume":"29","author":"H Seow","year":"2011","unstructured":"Seow H, Barbera L, Sutradhar R, Howell D, Dudgeon D, Atzema C, Liu Y, Husain A, Sussman J, Earle C (2011) Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol 29:1151\u20131158. https:\/\/doi.org\/10.1200\/jco.2010.30.7173","journal-title":"J Clin Oncol"},{"key":"10869_CR42","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1634\/theoncologist.2015-0026","volume":"20","author":"M Delgado-Guay","year":"2015","unstructured":"Delgado-Guay M, Ferrer J, Rieber AG, Rhondali W, Tayjasanant S, Ochoa J, Cantu H, Chisholm G, Williams J, Frisbee-Hume S et al (2015) Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist 20:1092\u20131098. https:\/\/doi.org\/10.1634\/theoncologist.2015-0026","journal-title":"Oncologist"},{"key":"10869_CR43","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1200\/jco.2015.63.2232","volume":"34","author":"CS Lathan","year":"2016","unstructured":"Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D (2016) Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol 34:1732\u20131740. https:\/\/doi.org\/10.1200\/jco.2015.63.2232","journal-title":"J Clin Oncol"},{"key":"10869_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35586","author":"SM Durbin","year":"2024","unstructured":"Durbin SM, Lundquist D, Pelletier A, Petrillo LA, Bame V, Turbini V, Heldreth H, Lynch K, Boulanger M, Lam A et al (2024) Financial toxicity in early-phase cancer clinical trial participants. Cancer. https:\/\/doi.org\/10.1002\/cncr.35586","journal-title":"Cancer"},{"key":"10869_CR45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jpainsymman.2018.12.003","volume":"57","author":"RJ Chan","year":"2019","unstructured":"Chan RJ, Gordon LG, Tan CJ, Chan A, Bradford NK, Yates P, Agbejule OA, Miaskowski C (2019) Relationships between financial toxicity and symptom burden in cancer survivors: a systematic review. J Pain Symptom Manage 57:646\u2013660. https:\/\/doi.org\/10.1016\/j.jpainsymman.2018.12.003","journal-title":"J Pain Symptom Manage"},{"key":"10869_CR46","doi-asserted-by":"publisher","first-page":"e1427","DOI":"10.1200\/op.21.00697","volume":"18","author":"S Perni","year":"2022","unstructured":"Perni S, Azoba C, Gorton E, Park ER, Chabner BA, Moy B, Nipp RD (2022) Financial toxicity, symptom burden, illness perceptions, and communication confidence in cancer clinical trial participants. JCO Oncol Pract 18:e1427\u2013e1437. https:\/\/doi.org\/10.1200\/op.21.00697","journal-title":"JCO Oncol Pract"},{"key":"10869_CR47","doi-asserted-by":"publisher","first-page":"e915","DOI":"10.1200\/op.21.00328","volume":"18","author":"HT Borno","year":"2022","unstructured":"Borno HT, Zhang L, Zhang S, Lin TK, Skafel A, Nieves E, Dornsife D, Johnson R, Rhoads K, Small Eea et al (2022) Implementation of a multisite financial reimbursement program in cancer clinical trials integrated with patient navigation: a pilot randomized clinical trial. JCO Oncol Pract 18:e915\u2013e924. https:\/\/doi.org\/10.1200\/op.21.00328","journal-title":"JCO Oncol Pract"},{"key":"10869_CR48","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1634\/theoncologist.2015-0481","volume":"21","author":"RD Nipp","year":"2016","unstructured":"Nipp RD, Lee H, Powell E, Birrer NE, Poles E, Finkelstein D, Winkfield K, Percac-Lima S, Chabner B, Moy B (2016) Financial burden of cancer clinical trial participation and the impact of a cancer care equity program. Oncologist 21:467\u2013474. https:\/\/doi.org\/10.1634\/theoncologist.2015-0481","journal-title":"Oncologist"},{"key":"10869_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/NJH.0b013e31826bfb63","volume":"15","author":"JL Krok","year":"2013","unstructured":"Krok JL, Baker TA, McMillan SC (2013) Age differences in the presence of pain and psychological distress in younger and older cancer patients. J Hosp Palliat Nurs 15:107\u2013113. https:\/\/doi.org\/10.1097\/NJH.0b013e31826bfb63","journal-title":"J Hosp Palliat Nurs"},{"key":"10869_CR50","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1007\/s00520-020-05415-y","volume":"28","author":"CA Cuthbert","year":"2020","unstructured":"Cuthbert CA, Boyne DJ, Yuan X, Hemmelgarn BR, Cheung WY (2020) Patient-reported symptom burden and supportive care needs at cancer diagnosis: a retrospective cohort study. Support Care Cancer 28:5889\u20135899. https:\/\/doi.org\/10.1007\/s00520-020-05415-y","journal-title":"Support Care Cancer"},{"key":"10869_CR51","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/cncr.29097","volume":"121","author":"EY Hanna","year":"2015","unstructured":"Hanna EY, Mendoza TR, Rosenthal DI, Gunn GB, Sehra P, Yucel E, Cleeland CS (2015) The symptom burden of treatment-naive patients with head and neck cancer. Cancer 121:766\u2013773. https:\/\/doi.org\/10.1002\/cncr.29097","journal-title":"Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10869-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10869-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10869-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:02:52Z","timestamp":1784052172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10869-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10869"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10869-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was done in accordance with the Declaration of Helsinki, and the institutional review board at Dana-Farber\/Harvard Cancer Center approved the study protocol.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants signed informed consent to participate in this study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"643"}}